Valuation: Devyser Diagnostics AB

Market Cap 1.11B 117M 101M 94.29M 86.5M 163M 11.11B 165M 434M 5.57B 438M 429M 18.41B P/E 2026 *
111x
P/E 2027 * 34.8x
Enterprise Value 1.06B 112M 96.68M 90.28M 82.82M 156M 10.64B 158M 416M 5.33B 420M 411M 17.63B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 3.59x
Free-Float
70.22%
Yield 2026 *
-
Yield 2027 * -
1 day-0.15%
1 week-0.91%
Current month-0.91%
1 month+12.54%
3 months-32.89%
6 months-39.58%
Current year-42.64%
1 week 63
Extreme 63
67.4
1 month 59.3
Extreme 59.3
69.9
Current year 57.8
Extreme 57.8
114.8
1 year 57.8
Extreme 57.8
159.6
3 years 57.4
Extreme 57.4
159.6
5 years 56.1
Extreme 56.1
159.6
10 years 56.1
Extreme 56.1
159.6
Manager TitleAgeSince
Chief Executive Officer 59 04/08/2025
Director of Finance/CFO 43 01/01/2021
Chief Tech/Sci/R&D Officer 48 01/02/2024
Director TitleAgeSince
Chairman 57 27/05/2021
Director/Board Member 49 01/01/2021
Director/Board Member 72 01/01/2021
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Buy

Director

250 0.0015%
31/07/26 Buy

Director

2,533 0.0152%
28/07/26 Buy

Director

7,944 0.0477%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-0.91%-56.56%-16.03% 117M
+0.99%+1.78%+4.07%+16.73% 49.47B
+3.71%+9.40%+486.98%+592.14% 43.61B
+2.70%+1.57%+33.39%+8.85% 39.29B
+5.60%+10.21%+16.76%+85.72% 39.6B
+2.21%+6.75%+21.31%+53.37% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+37.75%+126.84% 16.49B
-0.11%+2.41%+6.24%+18.87% 14.01B
+0.75%+15.04%+78.59%+30.30% 12.77B
Average +1.89%+5.60%+69.84%+101.87% 26.46B
Weighted average by Cap. +2.54%+6.09%+104.18%+140.71%

Financials

2026 *2027 *
Net sales 246M 25.95M 22.45M 20.96M 19.23M 36.17M 2.47B 36.74M 96.53M 1.24B 97.45M 95.32M 4.09B 298M 31.4M 27.16M 25.36M 23.27M 43.76M 2.99B 44.46M 117M 1.5B 118M 115M 4.95B
Net income 10.07M 1.06M 919K 858K 787K 1.48M 101M 1.5M 3.95M 50.67M 3.99M 3.9M 168M 31.97M 3.37M 2.92M 2.73M 2.5M 4.7M 321M 4.78M 12.55M 161M 12.67M 12.39M 532M
Net Debt -47.04M -4.96M -4.29M -4.01M -3.68M -6.92M -472M -7.03M -18.46M -237M -18.64M -18.23M -783M -39M -4.12M -3.56M -3.32M -3.05M -5.74M -392M -5.83M -15.31M -196M -15.45M -15.11M -649M
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change Volume
07/08/26 SEK 65.50 -0.15% 12,915
06/08/26 SEK 65.60 +3.14% 16,098
05/08/26 SEK 63.60 -2.75% 11,495
04/08/26 SEK 65.40 +0.31% 2,856
03/08/26 SEK 65.20 -1.36% 5,605
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.71DKK
Average target price
65.94DKK
Spread / Average Target
+47.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVYSR Stock